Anti-angiogenic activity of azathioprine.

doi:10.1016/j.mvr.2021.104234

Paper

Anti-angiogenic activity of azathioprine.

Published Aug 31, 2021 · Abel Vieira de Melo Bisneto, Amanda Silva Fernandes, Vivianne de Souza Velozo Sá

Microvascular research

Q2 SJR score

4

Citations

0

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Azathioprine shows potent anti-angiogenic activity, potentially benefiting anticancer treatment by decreasing TGF- and VEGF levels.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Paper

Anti-angiogenic activity of azathioprine.

References

Citations

A predictive model for premature atherosclerosis in systemic lupus erythematosus based on clinical characteristics.

This study developed a comprehensive nomogram to effectively predict premature atherosclerosis risk in SLE patients, aiding early identification and implementation of preventive measures.

Dioclea violacea lectin inhibits tumorigenesis and tumor angiogenesis in vivo.

Dioclea violacea seed mannose-binding lectin (DvL) is a potent anticancer, anti-angiogenic, and selective cytotoxic agent for tumor cells, suggesting its potential as a prototype molecule for developing new chemoprotective or antitumor drugs

Pedunculagin and tellimagrandin-I stimulate inflammation and angiogenesis and upregulate vascular endothelial growth factor and tumor necrosis factor-alpha in vivo.

Pedunculagin and tellimagrandin-I stimulate angiogenesis and inflammation, offering potential for use in neovascularization-based therapeutic approaches.

Anti-angiogenic effect of nano-formulated water soluble kaempferol and combretastatin in an in vivo chick chorioallantoic membrane model and HUVEC cells.

Nano-formulated water-soluble kaempferol and combretastatin effectively suppress angiogenesis by preventing endothelial cell activation and suppressing angiogenesis factors.